LONDON: The European Medicines Company will announce the conclusions of its investigation into the doable connection between AstraZeneca’s coronavirus vaccine and uncommon blood clots later Wednesday.
On Tuesday, a senior EMA official mentioned there was a causal hyperlink between the AstraZeneca vaccine and the uncommon blood clots which were seen in dozens of individuals worldwide, among the many tens of tens of millions who’ve acquired at the least one dose.
In feedback to Rome’s Il Messaggero newspaper, Marco Cavaleri, head of well being threats and vaccine technique on the Amsterdam-based company, mentioned “it’s changing into increasingly tough to affirm that there isn’t a cause-and-effect relationship between AstraZeneca vaccines and the very uncommon circumstances of blood clots related to a low degree of platelets.”
However Cavaleri acknowledged the company had not but discovered how precisely the vaccine may be inflicting these uncommon uncomfortable side effects.
